We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
ZandCell, a biotech company with a proven track record in immunotherapies and COVID-19 diagnostics is announcing that it wants to manufacture the Russian vaccines for worldwide distribution.